Genome sequencing identifies a basis for everolimus sensitivity Journal Article
| Authors: | Iyer, G.; Hanrahan, A. J.; Milowsky, M. I.; Al-Ahmadie, H.; Scott, S. N.; Janakiraman, M.; Pirun, M.; Sander, C.; Socci, N. D.; Ostrovnaya, I.; Viale, A.; Heguy, A.; Peng, L.; Chan, T. A.; Bochner, B.; Bajorin, D. F.; Berger, M. F.; Taylor, B. S.; Solit, D. B. |
| Article Title: | Genome sequencing identifies a basis for everolimus sensitivity |
| Keywords: | cancer survival; treatment response; unclassified drug; gene sequence; missense mutation; stop codon; drug targeting; sensitivity analysis; metastasis; progression free survival; gene expression; bladder cancer; tumor marker; dna; short survey; genome; base pairing; dna sequence; untranslated rna; tumor suppressor protein; tumor gene; loss of function mutation; everolimus; copy number variation; phase 2 clinical trial (topic); indel mutation; priority journal; neurofibromatosis type 2; tuberous sclerosis complex 1 |
| Journal Title: | Science |
| Volume: | 338 |
| Issue: | 6104 |
| ISSN: | 0036-8075 |
| Publisher: | American Association for the Advancement of Science |
| Date Published: | 2012-10-12 |
| Start Page: | 221 |
| Language: | English |
| DOI: | 10.1126/science.1226344 |
| PROVIDER: | scopus |
| PMCID: | PMC3633467 |
| PUBMED: | 22923433 |
| DOI/URL: | |
| Notes: | Short Survey -- Export Date: 13 November 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
